We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4B
AUM Growth
-$1.25B
(-24%)
Cap. Flow
-$1.28B
Cap. Flow
% of AUM
-32.02%
Top 10 Holdings %
Top 10 Hldgs %
20.82%
Holding
1,612
New
626
Increased
195
Reduced
208
Closed
487
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$10.2M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$6.08M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$5.95M |
| 4 |
Biogen
BIIB
|
+$5.94M |
| 5 |
Aon
AON
|
+$5.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$294M |
| 2 |
Lennar Class A
LEN
|
+$76.3M |
| 3 |
RH
RH
|
+$25.1M |
| 4 |
ARK Genomic Revolution ETF
ARKG
|
+$22.5M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.79% |
| 2 | Communication Services | 1.57% |
| 3 | Technology | 1.13% |
| 4 | Consumer Discretionary | 1.05% |
| 5 | Financials | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
PUT
Visa
V
$673B
| $4.45M | 0.11% |
21,000
-30,200
| -59% | -$6.36M |
|
202
CALL
Stem
STEM
$47.5M
| $4.44M | 0.11% |
+8,350
| New | +$5.36M |
|
|
ARVL
203
CALL
DELISTED
Arrival Ordinary Shares
ARVL
| $4.43M | 0.11% |
+5,522
| New | +$5.43M |
|
204
PUT
Cardlytics
CDLX
$22.1M
| $4.39M | 0.11% |
4,000
+300
| +8% | +$396K |
|
205
CALL
Gilead Sciences
GILD
$163B
| $4.36M | 0.11% |
67,400
+47,400
| +237% | +$3.06M |
|
206
PUT
Comcast
CMCSA
$84B
| $4.33M | 0.11% |
+80,000
| New | +$4.23M |
|
207
CALL
Las Vegas Sands
LVS
$32.3B
| $4.31M | 0.11% |
+71,000
| New | +$4.16M |
|
|
HOME
208
CALL
DELISTED
At Home Group Inc.
HOME
| $4.3M | 0.11% |
+150,000
| New | +$3.77M |
|
209
CALL
Wells Fargo
WFC
$258B
| $4.3M | 0.11% |
110,000
-60,000
| -35% | -$2.12M |
|
|
210
CALL
Jazz Pharmaceuticals
JAZZ
$16.2B
| $4.29M | 0.11% |
+26,100
| New | +$4.29M |
|
211
PUT
Devon Energy
DVN
$50.9B
| $4.28M | 0.11% |
+195,900
| New | +$4.03M |
|
212
CALL
Bank of America
BAC
$433B
| $4.28M | 0.11% |
110,600
+43,100
| +64% | +$1.49M |
|
213
Invesco S&P 500 Equal Weight ETF
RSP
$97.2B
| $4.25M | 0.11% |
+30,000
| New | +$4.05M |
|
214
CALL
JD.com
JD
$43.6B
| $4.22M | 0.11% |
50,000
+10,000
| +25% | +$917K |
|
|
RBAC
215
CALL
DELISTED
RedBall Acquisition Corp.
RBAC
| $4.18M | 0.1% |
+420,000
| New | +$4.43M |
|
216
CALL
Broadcom
AVGO
$1.85T
| $4.17M | 0.1% |
90,000
-10,000
| -10% | -$462K |
|
|
MILE
217
CALL
DELISTED
Metromile, Inc. Common Stock
MILE
| $4.17M | 0.1% |
405,500
+305,500
| +306% | +$4.66M |
|
218
Albemarle
ALB
$13.9B
| $4.16M | 0.1% |
+28,500
| New | +$4.57M |
|
219
CALL
LyondellBasell Industries
LYB
$19.5B
| $4.16M | 0.1% |
+40,000
| New | +$3.97M |
|
|
GES
220
CALL
DELISTED
Guess Inc
GES
| $4.16M | 0.1% |
+176,900
| New | +$4.36M |
|
221
Floor & Decor
FND
$5.98B
| $4.15M | 0.1% |
43,500
+13,500
| +45% | +$1.31M |
|
|
KLR
222
CALL
DELISTED
Kaleyra, Inc.
KLR
| $4.15M | 0.1% |
+84,143
| New | +$4.32M |
|
223
PUT
Opendoor
OPEN
$3.69B
| $4.13M | 0.1% |
201,500
+155,000
| +333% | +$4.09M |
|
|
HBI
224
CALL
DELISTED
Hanesbrands
HBI
| $4.13M | 0.1% |
+210,000
| New | +$3.72M |
|
|
SPLK
225
CALL
DELISTED
Splunk Inc
SPLK
| $4.06M | 0.1% |
30,000
| – | – |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q1 2021 Portfolio in Review
As of Q1 2021, SG3 Management held 1,612 positions worth $4B, down 24% from $5.25B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
SG3 Management withdrew a net $1.28B in Q1 2021, closing 487 positions and reducing 208 holdings. Its most notable exit was Amazon, an estimated $294M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 0.67% a quarter earlier, followed by Communication Services and Technology.
Against the trend, SG3 Management opened a new position in Albemarle worth $4.16M.
- SG3 Management's largest Q1 2021 buy was Albemarle: 28,500 shares worth $4.16M.
- SG3 Management added most to Jazz Pharmaceuticals in Q1 2021, an estimated $10.2M increase.
- SG3 Management's biggest Q1 2021 reduction was RH, cutting an estimated $25.1M.
- SG3 Management fully exited Amazon in Q1 2021, selling an estimated $294M.
- SG3 Management's ten largest holdings make up 21% of its $4B portfolio in Q1 2021.
- SG3 Management opened 626 new positions and closed 487 in Q1 2021.
- SG3 Management's portfolio value fell 24% quarter-over-quarter to $4B.
Based on SG3 Management's 13F filing for Q1 2021, filed 17 May 2021.